Found: 156
Select item for more details and to access through your institution.
Editorial: Chemo-Radiation-Resistance in Cancer Therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.904063
- By:
- Publication type:
- Article
The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.888280
- By:
- Publication type:
- Article
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.899633
- By:
- Publication type:
- Article
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.866827
- By:
- Publication type:
- Article
Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.867128
- By:
- Publication type:
- Article
The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.877706
- By:
- Publication type:
- Article
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.861642
- By:
- Publication type:
- Article
Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.843829
- By:
- Publication type:
- Article
Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.850862
- By:
- Publication type:
- Article
Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.843110
- By:
- Publication type:
- Article
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates.
- Published in:
- Journal of Evidence-Based Medicine, 2021, v. 14, n. 3, p. 232, doi. 10.1111/jebm.12434
- By:
- Publication type:
- Article
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1387, doi. 10.3390/ijms21041387
- By:
- Publication type:
- Article
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4095, doi. 10.3390/ijms20174095
- By:
- Publication type:
- Article
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 2, p. 268, doi. 10.3390/ijms20020268
- By:
- Publication type:
- Article
1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 38, n. 1, p. 185, doi. 10.1159/000438620
- By:
- Publication type:
- Article
B4G2 Induces Mitochondrial Apoptosis by the ROS-Mediated Opening of Ca<sup>2+</sup>-Dependent Permeability Transition Pores.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2015, v. 37, n. 3, p. 838, doi. 10.1159/000430212
- By:
- Publication type:
- Article
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41392-020-00300-w
- By:
- Publication type:
- Article
An Impact of COVID-19 on Cancer Care: An Update.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2072, doi. 10.3390/vaccines10122072
- By:
- Publication type:
- Article
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30217-7
- By:
- Publication type:
- Article
Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 11, p. 2745, doi. 10.1007/s11095-022-03184-3
- By:
- Publication type:
- Article
Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents.
- Published in:
- ChemMedChem, 2024, v. 19, n. 13, p. 1, doi. 10.1002/cmdc.202300715
- By:
- Publication type:
- Article
Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1.
- Published in:
- Scientific Reports, 2017, p. 42106, doi. 10.1038/srep42106
- By:
- Publication type:
- Article
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.
- Published in:
- Scientific Reports, 2016, p. 25694, doi. 10.1038/srep25694
- By:
- Publication type:
- Article
Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.732403
- By:
- Publication type:
- Article
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.720726
- By:
- Publication type:
- Article
OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.620874
- By:
- Publication type:
- Article
Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.615824
- By:
- Publication type:
- Article
Multidrug Resistance Proteins (MRPs) and Cancer Therapy.
- Published in:
- AAPS Journal, 2015, v. 17, n. 4, p. 802, doi. 10.1208/s12248-015-9757-1
- By:
- Publication type:
- Article
BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10).
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074573
- By:
- Publication type:
- Article
Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055576
- By:
- Publication type:
- Article
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01805-y
- By:
- Publication type:
- Article
Epigenetic modification of m<sup>6</sup>A regulator proteins in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01810-1
- By:
- Publication type:
- Article
Gold nanoparticles and gold nanorods in the landscape of cancer therapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01798-8
- By:
- Publication type:
- Article
New opportunities for RGD-engineered metal nanoparticles in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01784-0
- By:
- Publication type:
- Article
Advancements in nanoparticle-based treatment approaches for skin cancer therapy.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-022-01708-4
- By:
- Publication type:
- Article
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01531-x
- By:
- Publication type:
- Article
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01524-w
- By:
- Publication type:
- Article
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01587-9
- By:
- Publication type:
- Article
Proteomics technologies for cancer liquid biopsies.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01526-8
- By:
- Publication type:
- Article
m6A modification: recent advances, anticancer targeted drug discovery and beyond.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01510-2
- By:
- Publication type:
- Article
Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01519-7
- By:
- Publication type:
- Article
PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01512-0
- By:
- Publication type:
- Article
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01517-9
- By:
- Publication type:
- Article
Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-021-01480-x
- By:
- Publication type:
- Article
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-0946-x
- By:
- Publication type:
- Article
Synthesis and clinical application of new drugs approved by FDA in 2022.
- Published in:
- Molecular Biomedicine, 2023, v. 4, n. 1, p. 1, doi. 10.1186/s43556-023-00138-y
- By:
- Publication type:
- Article
RETRACTED: Ashar et al. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 2022, 12 , 1162.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 253, doi. 10.3390/biom13020253
- By:
- Publication type:
- Article
Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1162, doi. 10.3390/biom12081162
- By:
- Publication type:
- Article
Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01208
- By:
- Publication type:
- Article